Formula Growth’s Exact Sciences EXAS Stock Holding History

Formula Growth’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,600	Closed	-$1.45M	–	143
2021 Q4	$1.45M	Hold	18,600	–	–	0.26%	101
2021 Q3	$1.77M	Hold	18,600	–	–	0.25%	104
2021 Q2	$2.31M	Hold	18,600	–	–	0.32%	96
2021 Q1	$2.45M	Hold	18,600	–	–	0.35%	83
2020 Q4	$2.46M	Hold	18,600	–	–	0.41%	69
2020 Q3	$1.9M	Buy	18,600 +2,000	+12%	+$173K	0.35%	78
2020 Q2	$1.44M	Hold	16,600	–	–	0.24%	95
2020 Q1	$963K	Hold	16,600	–	–	0.18%	98
2019 Q4	$1.53M	Hold	16,600	–	–	0.19%	97
2019 Q3	$1.5M	Sell	16,600 -2,000	-11%	-$228K	0.22%	99
2019 Q2	$2.2M	Sell	18,600 -6,900	-27%	-$695K	0.31%	77
2019 Q1	$2.21M	Sell	25,500 -10,000	-28%	-$851K	0.31%	73
2018 Q4	$2.24M	Hold	35,500	–	–	0.37%	55
2018 Q3	$2.8M	Sell	35,500 -7,000	-16%	-$456K	0.32%	65
2018 Q2	$2.54M	Buy	42,500 +10,000	+31%	+$538K	0.28%	75
2018 Q1	$1.31M	Hold	32,500	–	–	0.16%	118
2017 Q4	$1.71M	Sell	32,500 -10,000	-24%	-$534K	0.22%	90
2017 Q3	$2M	Sell	42,500 -5,000	-11%	-$201K	0.32%	76
2017 Q2	$1.68M	Sell	47,500 -25,000	-34%	-$772K	0.29%	94
2017 Q1	$1.71M	Hold	72,500	–	–	0.36%	86
2016 Q4	$969K	Buy	72,500 +25,000	+53%	+$404K	0.23%	104
2016 Q3	$882K	Sell	47,500 -14,500	-23%	-$256K	0.2%	131
2016 Q2	$760K	Buy	+62,000	New	+$467K	0.19%	136

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Formula Growth's EXAS Position: Q1 2022 in Review

Formula Growth sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 18,600 shares — an estimated $1.45M sold.

Formula Growth first reported a position in EXAS in Q2 2016 and held it in 23 quarters. The position peaked at $2.8M in Q3 2018. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

Formula Growth reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
Formula Growth sold 18,600 Exact Sciences shares in Q1 2022, an estimated $1.45M.
Formula Growth first reported a position in Exact Sciences in Q2 2016 and held it in 23 quarters.
Formula Growth's Exact Sciences position peaked at $2.8M in Q3 2018.
559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Formula Growth's 13F filing for Q1 2022, filed 13 May 2022.